765.16MMarket Cap130.10P/E (TTM)
27.850High27.040Low352.49KVolume27.750Open27.610Pre Close9.68MTurnover1.30%Turnover RatioLossP/E (Static)28.01MShares35.84052wk High1.73P/B743.75MFloat Cap16.96552wk Low--Dividend TTM27.22MShs Float107.690Historical High--Div YieldTTM2.93%Amplitude9.260Historical Low27.460Avg Price1Lot Size
Castle Biosciences Stock Forum
New Data at ASTRO 2024 Shows Castle Biosciences’ DecisionDx®-SCC Test Provides More Precise Risk Stratification Than BWH Staging Alone to Guide Intensified Treatment for Immune Suppressed Patients with High-Risk Cutaneous Squamous Cell Carcinoma | CSTL Stock News
Businesswire· 4 mins ago
No comment yet